Enhanced HNRNPC expression is strongly associated with tumor stage advancement and metastasis development (84), and HNRNPC is considered a predictor for the response to immunotherapy in non-small cell lung cancer cells (85). The gene discussed is HNRNPC; the disease is neoplasm.